Suchergebnisse - "Musib, L."

PubPharm (15)

1

Antitumor activity of ipatasertib combined with chemotherapy : results from a phase Ib study in solid tumors

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Isakoff, S. | Tabernero, J. | Molife, L. | +18

2

A First-in-Human Phase I Study of the ATP-Competitive Akt Inhibitor Ipatasertib (GDC-0068) Demonstrates Robust and Safe Targeting of Akt in Patients with Solid Tumors

enthalten in: Cancer discovery | 2016

von Saura, C. | Roda, D. | Rosello, S. | +18

3

611 Assessment of CYP3A Inhibition, Food Effect, and Glucose/insulin Changes with Prednisone Co-administration in a Phase 1 Trial of the Oral, ATP-competitive Akt Inhibitor GDC-0068

enthalten in: The European journal of cancer / A | 2012

von Musib, L. | Budha, N. | Funke, R. | +7

4

Steady-State Carbamazepine Pharmacokinetics Following Oral and Stable-Labeled Intravenous Administration in Epilepsy Patients: Effects of Race and Sex

enthalten in: Clinical pharmacology & therapeutics | 2012

von Marino, S. | Birnbaum, A. | Leppik, I. | +10

5

Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients : effects of race and sex

enthalten in: Clinical pharmacology and therapeutics | 2012

von Marino, S. | Birnbaum, A. | Leppik, I. | +10

6

A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2010

von Glimelius, B. | Lahn, M. | Gawande, S. | +11

CommentIn: Ann Oncol. 2010 May;21(5):1127-8. - PMID 19914961

7

Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer

enthalten in: Annals of oncology | 2010

von Hanauske, A. | Lahn, M. | Musib, L. | +7

8

Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2009

von Hanauske, A. | Lahn, M. | Musib, L. | +7

9

9073 Pemetrexed (PEM) safety and pharmacokinetics (PK) in patients (pts) with third-space fluid (TSF): final results of a phase II study

enthalten in: European journal of cancer / EJC Supplements | 2009

von Sanchez-Torres, J. | Soerensen, J. | Paz-Ares, L. | +5

10

9073 Pemetrexed (PEM) safety and pharmacokinetics (PK) in patients (pts) with third-space fluid (TSF): final results of a phase II study

enthalten in: European journal of cancer / EJC Supplements | 2009

von Sanchez-Torres, J. | Soerensen, J. | Paz-Ares, L. | +5